Experimental ALS drug OK'd by Health Canada June 13, 2022 Health Canada has approved an experimental drug for amyotrophic lateral sclerosis, also known as ALS or Lou Gehrig's disease, as uncertainty persists about the drug's clinical benefit. Labels: CBC | Health News health Share to: Twitter Facebook URL Print Email
Post a Comment
Click to see the code!
To insert emoticon you must added at least one space before the code.